Fox Chase Cancer Center Appoints New Vice Chairman of Radiation Oncology
PHILADELPHIA (August 21, 2001) Fox Chase Cancer Center has appointed Benjamin Movsas, MD, vice chairman of the department of radiation oncology. Movsas came to Fox Chase in 1995. Most recently, he served as the department's director of clinical research and thoracic radiotherapy.
Stemming from his ongoing interest in clinical trials, Movsas has been a national principal investigator for several Radiation Therapy Oncology Group (RTOG) trials for non-small-cell lung cancer. He chairs the RTOG Quality of Life Committee and the Patterns of Care Lung Committee. He has also led several studies at Fox Chase to enhance the treatment and evaluation of patients with non-small-cell lung cancer, prostate cancer, rectal cancer and brain tumors.
Movsas graduated magna cum laude from Harvard University in 1986 with a degree in biochemistry and molecular biology. He received the Thomas T. Hoopes Award in recognition of having an outstanding senior thesis at Harvard.
Movsas went on to get his M.D. with a Distinguished Student Scholarship from Washington University School of Medicine.
He is a member of the honor societies Phi Beta Kappa and Alpha Omega Alpha.
He completed an internship in internal medicine at Sinai Hospital in Baltimore and his residency in radiation oncology at the National Cancer Institute's Radiation Oncology Branch in Bethesda, Md.
An invited lecturer across the country, Movsas is an author of numerous papers and abstracts found in notable publications. He is a member of the American Society of Clinical Oncology, American Society of Therapeutic Radiology and Oncology and the American College of Radiology and has served on the editorial board of the Journal of Clinical Oncology.
Movsas lives in Cherry Hill, New Jersey with his wife and four children.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.